BioCentury
ARTICLE | Company News

KV management update

June 21, 2010 7:00 AM UTC

KV Pharmaceutical Co. (NYSE:KVA), St. Louis Mo. Business: Drug delivery, Generics Promoted: Gregory Divis, president of Ther-Rx Corp., the branded pharmaceutical subsidiary of KV, to interim president...